Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

SHA:688180 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40,441	23,310	35,900	57,208	56,676	64,679
Market Cap Growth	15.27%	-35.07%	-37.25%	0.94%	-12.37%	245.58%
Enterprise Value	40,253	23,142	33,579	55,965	54,189	61,564
Last Close Price	42.72	27.33	41.83	62.60	66.98	81.10
PS Ratio	19.55	11.96	23.89	39.36	14.08	40.55
PB Ratio	7.13	3.93	4.90	5.84	6.82	11.10
P/TBV Ratio	7.92	4.37	5.44	6.08	7.38	11.42
EV/Sales Ratio	19.82	11.88	22.35	38.50	13.46	38.60
Debt / Equity Ratio	0.49	0.49	0.24	0.14	0.08	0.15
Asset Turnover	0.18	0.18	0.13	0.12	0.42	0.26
Inventory Turnover	0.91	0.93	1.12	0.97	3.04	1.44
Quick Ratio	1.13	1.40	1.91	3.57	2.42	2.77
Current Ratio	1.39	1.72	2.29	4.06	2.92	3.19
Return on Equity (ROE)	-21.12%	-20.83%	-29.63%	-28.52%	-10.33%	-37.90%
Return on Assets (ROA)	-7.13%	-7.65%	-12.94%	-14.63%	-4.51%	-17.07%
Return on Capital (ROIC)	-8.84%	-9.42%	-15.30%	-17.22%	-5.49%	-20.14%
Earnings Yield	-3.05%	-5.50%	-6.36%	-4.17%	-1.27%	-2.58%
FCF Yield	-4.26%	-9.12%	-7.90%	-3.77%	-2.66%	-3.15%
Buyback Yield / Dilution	-0.49%	-0.11%	-7.28%	-3.08%	-8.28%	-5.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.